Themasap Khan

Investing Profile

Sweet spot: $1.5M Range: $100K–$5M

Luma Group thesis

Whitepapers April 23, 2026 Rebuilding a Brittle Market: Regulatory Reform and the Return of Innovation in Osteoporosis Osteoporosis, a condition where bones become weak and brittle due to loss of bone density, is often seen as a natural part of aging, but it is more accurately a chronic disease caused by disrupted bone remodeling. 10 million Americans over age 50 have osteoporosis, and another 43 million have low bone mass.[1] Despite this, many patients remain undiagnosed and untreated. While existing therapies can reduce fracture risk, they do not provide a safe, effective long-term solution

Sector and stage focus

  • Series A: Consumer Health, BioTech, Health IT, Health & Hospital Services, Digital Health
  • Seed: BioTech, Consumer Health, Health IT, Digital Health, Health & Hospital Services
  • general: San Francisco Bay Area

Is Themasap Khan a fit for your round?

Upload your pitch deck and see whether Themasap Khan appears in your top 20 matches.

Find investors for your deck